CR

CREEK & RIVER Co.,Ltd.

A creator agency connecting professionals in creative, tech, medical, and legal sectors.

4763 | T

Overview

Corporate Details

ISIN(s):
JP3269700005
LEI:
Country:
Japan
Address:
港区新橋四丁目1番1号
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

CREEK & RIVER Co., Ltd. is a multifaceted professional agency that pioneered the "creator agency" business model in Japan. The company specializes in connecting its extensive network of skilled professionals with businesses across various industries for staffing, outsourcing, and consulting projects. While its origins and strengths lie in creative fields—including video, games, web, and advertising—the firm has expanded its services to encompass a diverse range of professional sectors such as medicine, law, accounting, architecture, and advanced technology like AI and XR. In addition to its core agency business, CREEK & RIVER provides content production and rights management services, leveraging its diverse talent pool to drive innovation for its partners.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-10-10 05:17
Report Publication Announcement
確認書
Japanese 8.1 KB
2025-10-10 05:17
Interim Report
半期報告書-第36期(2025/03/01-2026/02/28)
Japanese 241.2 KB
2025-06-02 09:46
Transaction in Own Shares
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 21.0 KB
2025-05-30 08:22
Post-Annual General Meeting Information
臨時報告書
Japanese 26.5 KB
2025-05-30 08:21
Governance Information
内部統制報告書-第35期(2024/03/01-2025/02/28)
Japanese 22.4 KB
2025-05-30 08:20
Registration Form
確認書
Japanese 8.2 KB
2025-05-30 08:19
Annual Report
有価証券報告書-第35期(2024/03/01-2025/02/28)
Japanese 2.9 MB
2025-05-01 09:13
Transaction in Own Shares
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 21.0 KB
2025-04-01 09:27
Transaction in Own Shares
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 21.0 KB
2025-03-21 07:58
Regulatory News Service
臨時報告書
Japanese 28.6 KB
2025-03-04 03:46
Transaction in Own Shares
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 21.0 KB
2025-02-03 07:47
Transaction in Own Shares
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 20.9 KB
2024-12-02 02:03
Transaction in Own Shares
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 21.0 KB
2024-11-06 01:53
Transaction in Own Shares
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 21.1 KB
2024-10-11 03:52
Interim Report
半期報告書-第35期(2024/03/01-2025/02/28)
Japanese 254.6 KB

Automate Your Workflow. Get a real-time feed of all CREEK & RIVER Co.,Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for CREEK & RIVER Co.,Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for CREEK & RIVER Co.,Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

FunPep Company Limited Logo
Biotech firm developing peptide-based therapeutics, cosmetics, and medical devices.
Japan
4881
Gain Therapeutics, Inc. Logo
Using an AI platform to develop allosteric therapies for neurodegenerative diseases.
United States of America
GANX
Galaxy Payroll Group Ltd Logo
APAC cross-border payroll, EOR, and corporate services for global businesses.
United States of America
GLXG
GATX CORP Logo
Global lessor of railcars, locomotives, and spare aircraft engines for key industries.
United States of America
GATX
GECOSS CORPORATION Logo
Leases and sells temporary steel materials and equipment for large construction projects.
Japan
9991
GENDAI AGENCY INC. Logo
Advertising agency providing marketing and promotions for the pachinko industry.
Japan
2411
Geneuro Logo
Developing antibody therapies targeting pathogenic HERVs for MS and post-COVID syndromes.
Switzerland
GEM
Developing long-acting immunotherapeutics for immuno-oncology and rare diseases.
South Korea
095700
GENFLOW BIOSCIENCES PLC Logo
Develops gene therapies to slow aging and treat age-related diseases in humans and dogs.
United Kingdom
GENF
GENINUS Inc. Logo
AI-powered genomic and multi-omics analysis for precision medicine and clinical partners.
South Korea
389030

Talk to a Data Expert

Have a question? We'll get back to you promptly.